IFNA2 and long COVID-19: In a recent study, 44% of patients with symptoms of PASC were found to have autoantibodies, including the ANAs Jo-1, Ro/SS-A, La/SS-B, U1-snRNP, P1, and anti-IFN-α2, approximately 2-3 months after initial symptom onset (285).